Back to search

Article

Patient-reported outcomes after switching from brand-name to generic drospirenone/ethinylestradiol combined oral contraceptives: a questionnaire-based observational study

2026-02-09

Abstract excerpt

<title>Abstract</title> <p>Background In Japan, the term “low-dose estrogen–progestin (LEP)” refers to combined oral contraceptive (COC) formulations that are pharmacologically equivalent to COCs but are primarily approved for therapeutic indications rather than contraception. Although bioequivalence between brand-name and generic formulations is required, patients sometimes report subjective differences after s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
632f002f-a588-5410-a5e8-8cd164e1a595
DOI
10.21203/rs.3.rs-8735703/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Patient-reported outcomes after switching from brand-name to generic drospirenone/ethinylestradiol combined oral contraceptives: a questionnaire-based observational studyDOI 10.21203/rs.3.rs-8735703/v1
Select a neighboring publication to make it the new centre.